Incyte Corporation
$97.47
$0.33(0.34%)
Incyte Corporation
INCY
$97.47
$0.33(0.34%)
Incyte Corporation
INCY
NASDAQ
$97.47
$0.33(0.34%)
Chart
Upcoming Earnings
Next report date
Aug 4, 2026
Report period
Q3 2026
EPS Estimate
$1.85
Revenue Estimate
$1.37B
Key stats
52-Week Range$97.47
$57.77
$112.29
Market capitalization
$19.47BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
13.49Basic EPS (TTM)
$6.60Net income (TTM)
$1.29BRevenue (TTM)
$5.14BAvg. volume
1.66MBeta (1Y)
0.80Employees
2.62KMarket capitalization
$19.47BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
13.49Basic EPS (TTM)
$6.60Net income (TTM)
$1.29BRevenue (TTM)
$5.14BAvg. volume
1.66MBeta (1Y)
0.80Employees
2.62KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Incyte Corporation
Sector
Healthcare
Industry
Biotechnology
CEO
William J. Meury
Website
www.incyte.comHeadquarters
1801 Augustine Cut-Off, Wilmington, DE, 19803
IPO Date
1993-11-04
Identifiers
ISIN
US45337C1027Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in...
Related Stocks
$175.30
1D:
4.2%
1Y:
10.9%
US09062X1037Healthcare
Mkt Cap
$25.72B
P/E Ratio TTM
20.1
Revenue TTM
$9.81B
Beta
0.16
Earnings TTM
$1.29B
Dividend Yield TTM
0.00%
$572.20
1D:
-1.6%
1Y:
91.6%
US91307C1027Healthcare
Mkt Cap
$25.08B
P/E Ratio TTM
18.9
Revenue TTM
$3.18B
Beta
0.75
Earnings TTM
$1.33B
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate